Catalio Genesis Fund IV, LLC

Late investment period

Late investment period: first sale Feb 2022, per Form D (fund age approximates vintage)

Vintage: 2022
Fund size: $10.05M to $11.31M (Form D and SEC adviser filing)
Stages: Not stated
Sectors: Biotech, Medical devices, Healthtech, Digital health, Life sciences and research tools
Regions: Not stated

01 · Thesis

Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners.Inferred from the firm's website

02 · Initial check

$101K to $188K (estimated from fund size)

Estimated from Form D and SEC adviser filing

03 · Who to approach

Named on this fund's Form D

Georgios Petrocheilos, Manager and Member of Manager of the Issuer
Rachel Vogelstein, Manager and Member of Manager of the Issuer

04 · Deals

No deals attributed to this fund yet.

05 · Evidence

Firm-wideCatalio invests in innovative healthcare companies at all stages and sizes, across the capital structure.
At Catalio, we invest in innovative healthcare companies at all stages and sizes, and throughout the capital structure.
https://cataliocapital.com/

06 · Sources

Last verified: Oct 28, 2026